# Codex Review: medical_monitoring_protected_surface_inventory_20260802

Date: 2026-08-02
Review mode: direct Codex metadata review; no delegated-agent output and no
provider/conference dispatch. The Hermes workflow guard task was initialized as a
recording scaffold only.

## Verdict

**PASS — metadata inventory only; ownership/authorization unresolved.**

This is not a semantic review of the medical-writing lane and does not clear the
release-ledger protection gap.

## Boundary Check

- Only the task-scoped context/review/metrics/evidence records were written.
- No product source, medical-writing source, shared frontend source, runtime,
  database, service, browser or provider was modified.
- The inventory used file metadata and SHA-256 only; no source semantics were read.
- 8911/5174 were not started. No 18911/PID 43191 action occurred.

## Codex Verification

- Exact mtime cohort: 66 files at local `2026-08-02 07:47:25 +0800`.
- Cohort path-list SHA-256:
  `ae32ae1f43b4af2c3728d3a6a8a7812d0faa2d3722eae99d3b99d77cea585280`.
- Code/test surfaces: 26; non-code record/handoff/run surfaces: 40.
- Protected/shared source surfaces: 22; supporting medical-writing QC/test surfaces: 5.
- Current sizes, mtimes and SHA-256 values are recorded in
  `records/active_slices/medical_monitoring_protected_surface_inventory_20260802/TASK_RECORD.md`.
- No tests were run because this was a read-only ownership-boundary inventory; that
  is intentional and not a test failure.

## Scope And Interpretation

The same-second mtime proves only that these bytes were present with that metadata
at capture time. It does not prove who changed them, whether the change is
authorized, or whether it is related to the monitoring lane. Historical handoff
hashes are not used as a current baseline because they differ in age and scope.

## Residual Risk / Required Handoff

An independent medical-writing owner must reconcile the cohort against its own
before/after diff and handoff. Until that occurs, medical-writing protection stays
**partial** in the release ledger. The monitoring lane must not claim the cohort as
its change, overwrite it, or broaden scanning. B6/C13 remain read-only and the next
monitoring gate remains formal B6 outcomes → aggregate/CAS replay → legacy
source-token revalidation.
